Financhill
Back

Invesco FTSE RAFI Dev Mkts ex-US ETF Vs. Disc Medicine Industry Stock Comparison

Sell
40

PXF
Invesco FTSE RAFI Dev Mkts ex-US ETF

Last Price:
48.89
Seasonality Move:
0.55%
Buy
80

IRON
Disc Medicine

Last Price:
44.62
Seasonality Move:
-19.23%
Sell
40
Invesco FTSE RAFI Dev Mkts ex-US ETF (PXF) is a Sell

Is Invesco FTSE RAFI Dev Mkts ex-US ETF a Buy, Sell or Hold?

  • The current Invesco FTSE RAFI Dev Mkts ex-US ETF [PXF] share price is $48.80. The Score for PXF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PXF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Disc Medicine (IRON) is a Buy

Is Disc Medicine a Buy, Sell or Hold?

  • The current Disc Medicine [IRON] share price is $44.99. The Score for IRON is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • IRON is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PXF Stock Price Chart

What is Invesco FTSE RAFI Dev Mkts ex-US ETF's stock price today?

  • The Invesco FTSE RAFI Dev Mkts ex-US ETF share price today is $48.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PXF is experiencing slight selling pressure.

IRON Stock Price Chart

What is Disc Medicine's stock price today?

  • The Disc Medicine share price today is $44.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IRON is experiencing slight selling pressure.

PXF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 38.74 Sell
Chaikin Money Flow: -66870 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.31 - 50.87) Sell
Bollinger Bands (100): (47.73 - 50.25) Sell

IRON Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.79 Buy
Relative Strength Index (14 RSI): 66.49 Buy
Chaikin Money Flow: -71565 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.31 - 42.09) Buy
Bollinger Bands (100): (30.05 - 63.09) Sell

PXF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.13 Sell
20-day SMA: 49.92 Sell
50-day SMA: 49.66 Sell
200-day SMA: 46.94 Buy
8-day EMA: 49.18 Sell
20-day EMA: 49.64 Sell
50-day EMA: 49.61 Sell
200-day EMA: 47.62 Buy

IRON Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.9 Buy
20-day SMA: 39 Buy
50-day SMA: 33.6 Buy
200-day SMA: 50.04 Sell
8-day EMA: 42.77 Buy
20-day EMA: 39.73 Buy
50-day EMA: 38.8 Buy
200-day EMA: 45.12 Sell

Invesco FTSE RAFI Dev Mkts ex-US ETF Earnings Growth & PXF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Disc Medicine Earnings Growth & IRON Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.39 per share, a decrease next quarter of $0.23 per share, a decrease this year of $1.62 per share, and a decrease next year of $0.43 per share.

Invesco FTSE RAFI Dev Mkts ex-US ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Disc Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):